CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

NCT00635492 · clinicaltrials.gov ↗

COMPLETED

Status

2515

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide
DRUG: any human insulin or analog insulin(s) given in any regimen by subcutaneous injection

Sponsor

AstraZeneca

Collaborators

[object Object]